Semaglutide 2•4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
Type 2 Diabetes patients have multiple associated co-morbidities such as overweight or obesity and Diabetes medications often result in weight gain which puts additional...